Skip to main content

Table 5 Familiarity with and preferences for effective treatment among caregivers of children under five with fever in the past two weeks

From: Monitoring fever treatment behaviour and equitable access to effective medicines in the context of initiatives to improve ACT access: baseline results and implications for programming in six African countries

 

Benin

DRC

Madagascar

Nigeria

Uganda

Zambia

 

N = 885

N = 2, 331

N = 1, 970

N = 2, 833

N = 1, 452

N = 1, 727

% Caregivers who name the national first-line drug when asked to list anti-malarials that they have heard of

13.5

3.1

3.5

6.9

57.2

81.1

% Caregivers who name the national first-line drug as the most effective anti-malarial for children under five

9.8

2.0

1.8

4.3

35.1

49.2

 

N = 381

N = 1, 186

N = 965

N = 1, 097

N = 898

N = 709

% Children treated with an anti-malarial that received a drug requested by their caregiver

37.5

35.8

51.9

21.3

14.1

7.9

Type of anti-malarial received, among children that received an anti-malarial requested by caregiver1

N = 143

N = 450

N = 549

N = 238

N = 127

N = 57

% Non-artemisinin

monotherapy

91.6

88.4

95.7

87.8

63.0

75.0

   % ACT

10.5

9.2

4.7

7.6

38.1

22.6

   % Artemisinin monotherapy

0.0

3.1

n/a

7.6

0.6

2.4

  1. 1 Categories are not mutually exclusive as some children received more than one anti-malarial